Antimalarial activity of phenazines from lapachol, β-lapachone and its derivatives against Plasmodium falciparum in vitro and Plasmodium berghei in vivo

Bioorganic and Medicinal Chemistry Letters

Volumn 14, Issue 5, 2004, Pages 1145-1149

  De Andrade Neto, Valter F ^a   Goulart, Marília O F ^b   Da Silva Filho, Jorge F ^b   Da Silva, Matuzalém J ^c   Pinto, Maria Do Carmo F R ^c   Pinto, Antônio V ^c   Zalis, Mariano G ^c   Carvalho, Luzia H ^a   Krettli, Antoniana U ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b FEDERAL UNIVERSITY OF ALAGOAS   (Brazil)

^c FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

1,2 NAPHTHOQUINONE; ANTIMALARIAL AGENT; BETA LAPACHONE; CHLOROQUINE; HYPOXANTHINE; LAPACHOL; MEFLOQUINE; PHENAZINE DERIVATIVE; TRITIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIMALARIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; DRUG COST; DRUG POTENCY; DRUG SYNTHESIS; IN VITRO STUDY; IN VIVO STUDY; MALARIA; MOUSE; NONHUMAN; PARASITEMIA; PLASMODIUM BERGHEI; PLASMODIUM FALCIPARUM;

PLASMODIUM BERGHEI; PLASMODIUM FALCIPARUM;

EID: 1242271971     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2003.12.069     Document Type: Article

References (35)

1. Kano S. Prog. Med. 21:2001;319.
2. Carvalho L.H., Brandão M.G.L., Santos-Filho D., Lopes J.L.C., Krettli A.U. Braz. J. Med. Biol. Res. 24:1991;1113.
3. Krettli A.U., Andrade-Neto V.F., Brandão M.G.L., Ferrari W.M.S. Mem. Inst. Oswaldo Cruz. 96:2001;1033.
4. Brandão M.G.L., Krettli A.U., Soares L.S.R., Nery C.G.C., Marinuzzi H. C. J. Ethnopharmacol. 57:1997;131.
5. McKeage K., Scott L.J. Drugs. 63:2003;597.
6. Thompson P.E., Werbel L.M. Antimalarial Agents. Chemistry and pharmacology De Stevens G. Medicinal Chemistry. A Series of Monographs. 1972;395 Academic, New York.
7. Carvalho L.H., Rocha E.M.M., Raslan D.S., Oliveira A.B., Krettli A. U. Braz. J. Med. Biol. Res. 21:1988;485.
8. Kapadia G.J., Azuine M.A., Balasubramanian V., Sridhar R. Pharm. Res. 43:2001;363.
9. Hooker S.C. J. Am. Chem. Soc. 58:1936;1181.
10. Glen V.L., Hutson P.R., Kehrli N.J., Boothman D.A., Wilding G.J. Chromatogr. B. Biomed. Sci. Appl. 25:1997;181.
11. Pardee A.B., Li Y.Z., Li C.J. Curr. Cancer Drug Targets. 2:2002;227.
12. Pinto C.N., De Moura K.C.G., Emery F.S., Pinto M.C.F.R., Castro S.L., Dantas A.P., Poloquevich P.F., Pinto A.V. Arzneim.-Forsch. 50:2000;1120.
13. Emoto T., Kubosaki N., Yamagiwa Y., Kamikawa T.A. Tetrahedron Lett. 41:2000;355.
14. Makgatho M.E., Anderson R., O'Sullivan J.F., Egan T.J., Freese J.A., Cornelius N., van Rensburg C.E.J. Drug Develop. Res. 50:2000;195.
15. Wang W.Y., Preville P., Morin N., Mounir S., Cai W.Z., Siddiqui M.A. Bioorg. Med. Chem. Lett. 10:2000;1151.
16. Rewcastle G.W., Denny W.A., Baguley B.C. J. Med. Chem. 30:1987;843.
17. Hooker S.C. J. Chem. Soc. 63:1893;1376.
18. Di Chenna P.H., Benedetti-Doctorovich V., Baggio R.F., Garland M.T., Burton G. J. Med. Chem. 44:2001;2485.
19. Portugal S.G.M., Herrera J.O., Brinn I.M. Bull. Chem. Soc. Jpn. 70:1997;2071.
20. Lopes J.N., Cruz F.S., Do Campo R., Vasconcellos M.E., Sampaio M.C.R., Pinto A.V., Gilbert B. Ann. Trop. Medic. and Parasit. 72:1978;1.
21. Pereira M.A. A structural analysis of lapachol and β-lapachones, PhD thesis, São Paulo University. 1989;São Carlos/SP, Brazil.
22. Carvalho C.E.M., Brinn I.M., Pinto A.V., Pinto M.C.F.R. J. Photochem. Photobiol. A: Chem. 136:2000;25.
23. 3) δ H 9.42-9.39 (m, ArH); 8.38-8.26 (m, 2 ArH); 8.03-7.75 (m, 7 ArH).
24. Hooker S.C. J. Am. Chem. Soc. 58:1936;1190.
25. Benedetti-Doctorovich V., Escola N., Burton G. Magn. Res. Chem. 36:1998;529.
26. Kehrmann F., Mermod C. Helv. Chim. Acta. 10:1927;65.
27. 50) values were determined by linear regression analyses of the linear segments of the curves.
28. Trager W., Jensen J.B. Science. 193:1976;673.
29. Lambros C., Vanderberg J.P. J. Parasitol. 65:1979;418.
30. Zalis M.G., Pang L., Silveira M.S., Milhous W.K., Wirth D.F. Am. J. Trop. Med. Hyg. 58:1998;630.
31. 33 All phenazines were tested in 3 independent experiments. For 6a, an additional experiment was performed, using a 7-day schedule, by subcutaneous route, with parasitaemia monitored at several days after inoculation.
32. Peters W. Exp. Parasitol. 17:1965;80.
33. Andrade-Neto V.F., Brandão M.G.L., Stehmann J.R., Oliveira L.A., Krettli A.U. J. Ethnopharmacol. 87:2003;253.
34. Ren H., Grady S., Gamenara D., Heinzen H., Moyna P., Croft S.L., Kendrick H., Yardley V., Moyna G. Bioorg. Med. Chem. Lett. 11:2001;1851.
35. Zani C.L., Chiari E., Krettli A.U., Murta S.M.F., Cunningham M.L., Fairlamb A.H., Romanha A.J. Bioorg. Med. Chem. 5:1997;2185.